What is Harm Reduction Coalition?
Harm Reduction Coalition operates as a national advocacy and capacity-building entity dedicated to enhancing the health and dignity of individuals and communities affected by drug use. The organization's comprehensive approach tackles critical issues such as overdose prevention, the spread of HIV and hepatitis C, addiction, and the impacts of incarceration. By addressing the root causes of drug-related harm, including social inequality and injustice, the Coalition champions policies, practices, and programs that empower vulnerable populations and ensure their voices are heard in public policy discussions. Their work is foundational to fostering a society that upholds the right to health and well-being for all.
How much funding has Harm Reduction Coalition raised?
Harm Reduction Coalition has raised a total of $1.1M across 2 funding rounds:
Unspecified
$750K
Debt
$350K
Unspecified (2019): $750K with participation from CVS Health
Debt (2020): $350K led by PPP
Key Investors in Harm Reduction Coalition
CVS Health
CVS Health is a major healthcare corporation focused on delivering accessible and affordable health solutions, likely supporting Harm Reduction Coalition's mission through its extensive reach and commitment to consumer well-being.
PPP
Public-Private Partnership
What's next for Harm Reduction Coalition?
With the recent infusion of major strategic investment, Harm Reduction Coalition is poised to expand its advocacy reach and capacity-building efforts. This capital injection is expected to fuel the scaling of its programs, enhance policy development initiatives, and strengthen its support for communities most impacted by drug use. The organization's focus on addressing systemic inequalities suggests a strategic direction aimed at long-term societal change and improved public health outcomes, positioning it for continued influence in the harm reduction landscape.
See full Harm Reduction Coalition company page
